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Blood Transfusion Requirements for Patients on Extracorporeal Membrane 
Oxygenation 
Min Choi, Hitoshi Hirose MD, PhD* 
Department of Surgery, Thomas Jefferson University, Philadelphia, PA. 
(*) indicates primary project advisor 
 
Introduction: Extracorporeal membrane oxygenation (ECMO) is a rescue device used 
for cardiac and pulmonary dysfunction.  Patients on ECMO often require blood 
transfusions from bleeding complications.  Goals of the study are to determine: 1) 
transfusion requirements while on ECMO, 2) incidence of bleeding complications, 3) 
transfusion requirements for bleeding complications. 
Methods: Packed Red Blood Cell (PRBC) transfusions and bleeding complications 
were identified by retrospective chart review of patients on ECMO from 2010 to 2018 at 
our institution.  Patients were categorized into those who did not bleed (group A) and 
those who bled (group B).  Site, incidence, and transfusion requirement for each 
bleeding event were determined. 
Results: Among a total of 217 patients, we identified 62 patients (29%) without bleeding 
complications (group A) and 155 patients (71%) with bleeding complications (group B).  
PRBC transfusion requirement was higher in group B (1.6 PRBC/day) than group A (0.5 
PRBC/day) [p=<0.0001].  In group A, number of PRBC requirements was 0.6 PRBC/day 
for VA ECMO (n=42) and 0.2 PRBC/day for VV ECMO (n=20) [p=0.0015].  In group B, 
number of PRBC requirements was 1.8 PRBC/day for VA ECMO (n=106) and 1.1 
PRBC/day for VV ECMO (n=49) [p=0.0006].  In group B, incidence and number of 
PRBC given per major bleeding complication during ECMO were: mediastinal/thoracic 
bleed (7.3 PRBC, n=84), GI bleed (7.1 PRBC, n=59), cannulation site bleed (5.2 PRBC, 
n=88), and ENT bleed (4.1 PRBC, n=103). 
Discussion: Transfusion requirements increased once patients developed bleeding 
complications. Patients on VA ECMO required more PRBC/day compared to those on 
VV ECMO. 
